In the following sections, we examine how disturbances in the RKIP–YY1 axis contribute to the pathogenesis of obesity, diabetes, and atherosclerosis, and highlight emerging opportunities for targeted therapeutic modulation. Here, YY1 is linked to obesity due to melanocortin 4 receptor deficiency.